Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
Americas
Clear all
Type of publications
NITAG documentation
(105)
Scientific publications
(3)
Systematic reviews (SYSVAC)
(8)
Topics
Regions
Americas
(116)
Countries
Canada
(116)
Argentina
(30)
Bolivia
(3)
Brazil
(4)
Chile
(66)
Colombia
(1)
Costa Rica
(1)
Honduras
(14)
Mexico
(1)
Nicaragua
(1)
Peru
(2)
United States of America
(430)
Uruguay
(2)
Diseases
COVID-19
(41)
Diphtheria
(2)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(20)
Measles
(1)
Meningococcal disease
(7)
Mpox // Monkeypox
(2)
Mumps
(1)
Pertussis
(2)
Pneumococcal disease
(7)
Rabies
(1)
Rotavirus
(2)
Rubella
(1)
Tuberculosis
(1)
Varicella
(4)
Publication date
2024
(1)
2023
(11)
2022
(21)
2021
(19)
2020
(10)
2019
(4)
2018
(5)
2017
(4)
2016
(3)
2015
(6)
2014
(8)
2013
(1)
2010
(11)
2009
(4)
2008
(5)
2006
(1)
2005
(1)
Target population
Adolescents
(2)
Adults
(5)
All age groups
(6)
Children
(1)
Healthcare workers
(3)
Newborn
(1)
Older adults
(5)
Parents/caregivers
(1)
Pregnant women
(2)
Available to download in languages
English (EN)
(91)
French (FR)
(38)
116 results found
2020
∙
NACI
Research priorities for COVID-19 vaccines to support public health decisions
2020
∙
NACI
The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease
2019
∙
Poliquin, V. Greyson, D. Castillo, E.
A Systematic Review of Barriers to Vaccination During Pregnancy in the Canadian Context
2019
∙
Faust, L. Schreiber, Y. Bocking, N.
A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities
2019
∙
NACI
Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2019–2020
2019
∙
NACI
The Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease
2018
∙
NACI
Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019
2018
∙
NACI
Literature review - Update on immunization in pregnancy with Tdap vaccine
2018
∙
NACI
Literature Review on Individuals with Neurologic or Neurodevelopment Conditions and Risk of Serious Influenza-Related Complications
2018
∙
NACI
Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone® High-Dose) and MF59-Adjuvanted (Fluad®) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register